Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.

Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI.

J Clin Oncol. 2013 Jan 20;31(3):314-20. doi: 10.1200/JCO.2012.42.4101. Epub 2012 Dec 10.

2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
3.

Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

Papaioannou D, Rafia R, Rathbone J, Stevenson M, Buckley Woods H, Stevens J.

Health Technol Assess. 2012;16(37):1-253, iii-iv. Review.

4.

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.

Keating GM.

Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000. Review.

PMID:
20614951
5.

The role of mitoxantrone in the treatment of indolent lymphomas.

Hagemeister F, Cabanillas F, Coleman M, Gregory SA, Zinzani PL.

Oncologist. 2005 Feb;10(2):150-9. Review.

6.

Radioimmunotherapy in follicular lymphoma.

Illidge T, Morschhauser F.

Best Pract Res Clin Haematol. 2011 Jun;24(2):279-93. doi: 10.1016/j.beha.2011.03.005. Epub 2011 May 12. Review.

PMID:
21658624
7.

Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?

Kumar A, Sundararajan S, Puvvada S, Persky DO.

Curr Treat Options Oncol. 2016 Sep;17(9):45. doi: 10.1007/s11864-016-0424-2. Review.

PMID:
27423794
8.

[Treatment of aggressive lymphomas].

Gleissner B, Zwick C, Pfreundschuh M.

Internist (Berl). 2007 Apr;48(4):389-95. Review. German.

PMID:
17361405
9.

Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.

Buchegger F, Larson SM, Mach JP, Chalandon Y, Dietrich PY, Cairoli A, Prior JO, Romero P, Speiser DE.

Clin Dev Immunol. 2013;2013:875343. doi: 10.1155/2013/875343. Epub 2013 Nov 26. Review.

10.

Advanced-stage III/IV follicular lymphoma: treatment strategies for individual patients.

Heinzelmann F, Ottinger H, Engelhard M, Soekler M, Bamberg M, Weinmann M.

Strahlenther Onkol. 2010 May;186(5):247-54. doi: 10.1007/s00066-010-2091-8. Epub 2010 Apr 26. Review.

PMID:
20437015
11.

Pros and cons of rituximab maintenance in follicular lymphoma.

Zhang L, Ghielmini M, Cheson BD, Ujjani C.

Cancer Treat Rev. 2017 Jul;58:34-40. doi: 10.1016/j.ctrv.2017.05.007. Epub 2017 Jun 16. Review.

PMID:
28628883
12.

Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma.

Sánchez Ruiz AC, de la Cruz-Merino L, Provencio Pulla M.

Ther Adv Hematol. 2014 Jun;5(3):78-90. doi: 10.1177/2040620714532282. Review.

13.

Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

Chatal JF, Kraeber-Bodéré F, Barbet J.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1236-9. doi: 10.1007/s00259-008-0727-z. Review. No abstract available.

PMID:
18330570
14.

PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.

Nachat A, Turoff-Ortmeyer S, Liu C, Mcculloch M.

Perm J. Spring 2016;20(2):74-80. doi: 10.7812/TPP/15-153. Review.

15.

How we manage follicular lymphoma.

Hiddemann W, Cheson BD.

Leukemia. 2014 Jul;28(7):1388-95. doi: 10.1038/leu.2014.91. Epub 2014 Feb 28. Review.

PMID:
24577532
16.

Follicular Lymphoma: The Management of Elderly Patient.

Castellino A, Santambrogio E, Nicolosi M, Botto B, Boccomini C, Vitolo U.

Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017009. doi: 10.4084/MJHID.2017.009. eCollection 2017. Review.

17.

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma.

Aguiar-Bujanda D, Blanco-Sánchez MJ, Hernández-Sosa M, Galván-Ruíz S, Hernández-Sarmiento S.

Cancer Manag Res. 2015 Oct 27;7:319-30. doi: 10.2147/CMAR.S69145. eCollection 2015. Review.

Supplemental Content

Support Center